ARTERIAL HYPERTENSION AND COMORBID CONDITIONS: TYPE 2 DIABETES MELLITUS AND OBESITY
DOI:
https://doi.org/10.30890/2709-2313.2023-25-00-014Keywords:
Arterial hypertension, type 2 diabetes mellitus, obesityAbstract
Arterial hypertension (AH) remains among the most common cardiovascular diseases (CVDs) worldwide and in Ukraine in particular, which results in its significant impact on public health indicators. Elevated BP tends to be a major cardiovascular risk factorMetrics
References
Ott C, Schmieder RE. Diagnosis and treatment of arterial hypertension 2021. Kidney Int. 2022 Jan;101(1):36-46. doi: 10.1016/j.kint.2021.09.026. Epub 2021 Oct 29. PMID: 34757122.
Lauder L, Mahfoud F, Azizi M, Bhatt DL, Ewen S, Kario K, Parati G, Rossignol P, Schlaich MP, Teo KK, Townsend RR, Tsioufis C, Weber MA, Weber T, Böhm M. Hypertension management in patients with cardiovascular comorbidities. Eur Heart J. 2023 Jun 20;44(23):2066-2077. doi: 10.1093/eurheartj/ehac395. PMID: 36342266.
Fix GM, Cohn ES, Solomon JL, Cortés DE, Mueller N, Kressin NR, Borzecki A, Katz LA, Bokhour BG. The role of comorbidities in patients' hypertension self-management. Chronic Illn. 2014 Jun;10(2):81-92. doi: 10.1177/1742395313496591. Epub 2013 Jul 26. PMID: 23892774; PMCID: PMC8887829.
Jordan J, Kurschat C, Reuter H. Arterial Hypertension. Dtsch Arztebl Int. 2018 Aug 20;115(33-34):557-568. doi: 10.3238/arztebl.2018.0557. PMID: 30189978; PMCID: PMC6156553.
Jordan J, Birkenfeld AL. Cardiometabolic crosstalk in obesity-associated arterial hypertension. Rev Endocr Metab Disord. 2016 Mar;17(1):19-28. doi: 10.1007/s11154-016-9348-1. PMID: 26961160.
Moon MK, Noh J, Rhee EJ, Park SH, Kim HC, Kim BJ, Kim HJ, Choi S, Na JO, Hyun YY, Kim BJ, Han KD, Jeong IK. Cardiovascular Outcomes according to Comorbidities and Low-Density Lipoprotein Cholesterol in Korean People with Type 2 Diabetes Mellitus. Diabetes Metab J. 2023 Jan;47(1):45-58. doi: 10.4093/dmj.2021.0344. Epub 2023 Jan 26. PMID: 36727163; PMCID: PMC9925148.
Teck J. Diabetes-Associated Comorbidities. Prim Care. 2022 Jun;49(2):275-286. doi: 10.1016/j.pop.2021.11.004. Epub 2022 Apr 22. PMID: 35595482.
Halasz G, Parati G, Piepoli MF. Editorial comments: focus on arterial hypertension and co-morbidities. Eur J Prev Cardiol. 2023 Jan 11;30(1):1-3. doi: 10.1093/eurjpc/zwac301. PMID: 36583952.
Zhang C, Li Z, Liu L, Pu Y, Zou X, Yan H, Pan Y, Zhao X, Wang Y, Wang Y. The role of hypertension and diabetes mellitus on the etiology of middle cerebral artery disease. Brain Behav. 2022 Apr;12(4):e2521. doi: 10.1002/brb3.2521. Epub 2022 Mar 20. PMID: 35307987; PMCID: PMC9014985.
Mancia G, Hall JE. Introduction to a Compendium on the Pathophysiology and Treatment of Hypertension. Circ Res. 2019 Mar 29;124(7):967-968. doi: 10.1161/CIRCRESAHA.119.314953. PMID: 30920925.
Mannemuddhu SS, Ojeda JC, Yadav A. Renovascular Hypertension. Prim Care. 2020 Dec;47(4):631-644. doi: 10.1016/j.pop.2020.08.009. Epub 2020 Oct 1. PMID: 33121633.
Jia G, Sowers JR. Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease. Hypertension. 2021 Nov;78(5):1197-1205. doi: 10.1161/HYPERTENSIONAHA.121.17981. Epub 2021 Oct 4. PMID: 34601960; PMCID: PMC8516748.
Pavlou DI, Paschou SA, Anagnostis P, Spartalis M, Spartalis E, Vryonidou A, Tentolouris N, Siasos G. Hypertension in patients with type 2 diabetes mellitus: Targets and management. Maturitas. 2018 Jun;112:71-77. doi: 10.1016/j.maturitas.2018.03.013. Epub 2018 Mar 30. PMID: 29704920.
Kim HJ, Kim KI. Blood Pressure Target in Type 2 Diabetes Mellitus. Diabetes Metab J. 2022 Sep;46(5):667-674. doi: 10.4093/dmj.2022.0215. Epub 2022 Sep 19. PMID: 36193727; PMCID: PMC9532171.
Reichert KP, Castro MFV, Assmann CE, Bottari NB, Miron VV, Cardoso A, Stefanello N, Morsch VMM, Schetinger MRC. Diabetes and hypertension: Pivotal involvement of purinergic signaling. Biomed Pharmacother. 2021 May;137:111273. doi: 10.1016/j.biopha.2021.111273. Epub 2021 Jan 30. PMID: 33524787; PMCID: PMC7846467.
Andersson C, Nayor M, Tsao CW, Levy D, Vasan RS. Framingham Heart Study: JACC Focus Seminar, 1/8. J Am Coll Cardiol. 2021 Jun 1;77(21):2680-2692. doi: 10.1016/j.jacc.2021.01.059. PMID: 34045026.
Shalimova A, Fadieienko G, Kolesnikova O, Isayeva A, Zlatkina V, Nemtsova V, Prosolenko K, Psarova V, Kyrychenko N, Kochuieva M. The Role of Genetic Polymorphism in the Formation of Arterial Hypertension, Type 2 Diabetes and their Comorbidity. Curr Pharm Des. 2019;25(3):218-227. doi: 10.2174/1381612825666190314124049. PMID: 30868946.
Seravalle G, Grassi G. Obesity and hypertension. Pharmacol Res. 2017 Aug;122:1-7. doi: 10.1016/j.phrs.2017.05.013. Epub 2017 May 19. PMID: 28532816.
Tousoulis D. Arterial hypertension: New concepts in diagnosis and treatment? Hellenic J Cardiol. 2020 May-Jun;61(3):145-147. doi: 10.1016/j.hjc.2020.08.003. Epub 2020 Aug 21. PMID: 32835808.
Hengel FE, Sommer C, Wenzel U. Arterielle Hypertonie – Eine Übersicht für den ärztlichen Alltag [Arterial Hypertension]. Dtsch Med Wochenschr. 2022 Apr;147(7):414-428. German. doi: 10.1055/a-1577-8663. Epub 2022 Mar 28. PMID: 35345049.
Silva BV, Sousa C, Caldeira D, Abreu A, Pinto FJ. Management of arterial hypertension: Challenges and opportunities. Clin Cardiol. 2022 Nov;45(11):1094-1099. doi: 10.1002/clc.23938. Epub 2022 Nov 24. PMID: 36423356; PMCID: PMC9707556.
Hebebrand J. Welcome to OBESITY FACTS, the official journal of the European Association for the Study of Obesity (EASO)! Obes Facts. 2008;1(1):4-5. doi: 10.1159/000116618. Epub 2008 Feb 25. PMID: 20054155; PMCID: PMC6444513.
Bray GA, Kim KK, Wilding JPH; World Obesity Federation. Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obes Rev. 2017 Jul;18(7):715-723. doi: 10.1111/obr.12551. Epub 2017 May 10. PMID: 28489290.
Rao G. Diagnosis, Epidemiology, and Management of Hypertension in Children. Pediatrics. 2016 Aug;138(2):e20153616. doi: 10.1542/peds.2015-3616. Epub 2016 Jul 12. PMID: 27405770.
Ruden, V.V.. (2023). The main causes of death among the population of Ukraine during 2005–2021. Ukraine. Nation’s Health. 74-80. 10.32782/2077-6594/2023.1/12.
Lechner K, Schunkert H. Personalisierte Behandlungskonzepte bei arterieller Hypertonie [Personalized treatment concepts for arterial hypertension]. Herz. 2021 Feb;46(1):91-104. German. doi: 10.1007/s00059-020-05010-1. PMID: 33433651.
Antza C, Doundoulakis I, Stabouli S, Kotsis V. American, European and international hypertension guidelines: Time to shake hands? Int J Cardiol Hypertens. 2020 Dec 17;8:100075. doi: 10.1016/j.ijchy.2020.100075. PMID: 33884368; PMCID: PMC7803036.
Böhm M, Pogue J, Kindermann I, Pöss J, Koon T, Yusuf S. Effect of comorbidities on outcomes and angiotensin converting enzyme inhibitor effects in patients with predominantly left ventricular dysfunction and heart failure. Eur J Heart Fail. 2014 Mar;16(3):325-33. DOI: 10.1002/ejhf.23.
Abuissa H, Jones PG, Marso SP, O’Keefe JH Jr. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials. J Am Coll Cardiol. 2005 Sep 6;46(5):821-6. DOI: 10.1016/j.jacc.2005.05.051.
Pfeffer MA, Claggett B, Lewis EF, Granger CB, Køber L, Maggioni AP, et al. Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction. N Engl J Med. 2021 Nov 11;385(20):1845-1855. DOI: 10.1056/NEJMoa2104508. Erratum in: N Engl J Med. 2021 Dec 30;385(27):2592
Pertseva N. Dynamics of Endothelial Function Impairment in Patients with Initial Poor Compensation of Type 2 Diabetes Mellitus in Correction of Hypertension with Angiotensin II Receptor Antagonists during a year. Mìžnarodnij endokrinologìčnij žurnal [Internet]. 2022 Feb 18 [cited 2023 May 21];7(63):13-7. Available from: https://iej.zaslavsky.com.ua/index. php/journal/article/view/837.
Chmyr N. Dynamics of endocrine and metabolic changes among patients with coronary artery disease, type 2 diabetes mellitus and metabolic syndrome while treating with telmisartan. Mìžnarodnij endokrinologìčnij žurnal [Internet]. 2022 Mar 27 [cited 2023 May 21];18(1):22-35. Available from: https://iej.zaslavsky.com.ua/index.php/journal/article/view/1142.
Rekovets OL, Sirenko YM, Torbas OO, Kushnir CM, Prymak GF. Vplyv blokatoriv retseptoriv anhiotenzynu II na zminy ofisnoho, tsentralʹnoho arterialʹnoho tysku ta tsyrkadnistʹ arterialʹnoho tysku zalezhno vid rankovoho abo vechirnʹoho pryyomu. UKZH [Internet]. 2019 Hrud 24 [cited 2023 Trav 21];26(5):23-2. Dostupno: https://ucardioj.com.ua/index. php/UJC/article/view/195.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Authors
This work is licensed under a Creative Commons Attribution 4.0 International License.
